Sheba and the NIH join forces to develop a revolutionary pan-Coronavirus vaccine
The COVID-19 pandemic had a devastating impact on the world, and while things have mostly returned to normal, experts warn that a new strain can put millions at risk again.
A global leader in the fight against COVID-19, Sheba established the
Sheba Pandemic Research Institute (SPRI) in preparation for future outbreaks.
SPRI develops the medical advances and technologies needed to respond rapidly to global epidemiological crises, focusing on appropriate preventive measures and biological countermeasures.
Recently, SPRI partnered with the United States National Institutes of Health (NIH), Walter Reed Army Institute of Research, and the pharmaceutical company Sanofi to develop a pan-coronavirus vaccine that will provide long-term solutions to current and future strains.
We thank Sheba for paving the way for a better tomorrow, making a significant contribution to Israel, Africa, and the world at large.
Resilience Amid Adversity: Nadav’s Journey to Recovery
Nadav’s heroic journey from a harrowing ordeal to specialized care at Sheba Medical Center showcases resilience and the essential role of expert medical attention in times of crisis.
Bravery Knows No Age: 4-year-old Shani’s Battle Against Cancer Amidst Conflict
Shani Avital’s journey is a tale of resilience against brain cancer and conflict, symbolizing hope amidst adversity at Sheba Hospital.
Surviving Adversity: Amichai’s Resilience in the Face of Tragedy
On October 7th Amichai put himself in the line of fire for the safety of his family and survived a grenade attack to protect his family. He then started on the path to recovery at Sheba.
